ClinConnect ClinConnect Logo
Search / Trial NCT02354742

Echo vs. EGDT in Severe Sepsis and Septic Shock

Launched by INTERMOUNTAIN HEALTH CARE, INC. · Feb 2, 2015

Trial Information

Current as of June 28, 2025

Completed

Keywords

Echocardiography Egdt Sepsis

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • At least 18 years of age
  • Suspected infection
  • Two or more systemic inflammatory response syndrome (SIRS) criteria
  • White blood cell count less than 4,000 per mm3, greater than 12,000 per mm3, or differential with greater than 10% immature forms
  • Heart rate greater than 90 beats per minute
  • Respiratory rate greater than 20 breaths per minute or paCO2 less than 32 mmHg
  • Temperature less than 36°C or greater than 38°C
  • * Evidence of refractory hypoperfusion attributed to sepsis (one or more of the following):
  • Systolic blood pressure less than 90 mmHg despite an intravenous fluid challenge of at least 30ml/kg (a portion of this may be albumin equivalent)
  • Blood lactate level at least 4 mmol/L.
  • Intention to place an arterial catheter.
  • Intention to place a central venous catheter.
  • Exclusion criteria:
  • Known pregnancy
  • Requirement for immediate surgery
  • Hypotension attributed to alternative cause
  • Treating physician deems the patient is moribund
  • Treating physician deems aggressive care is unsuitable
  • Contraindication to central venous catheterization or arterial catheterization
  • Advanced directives restricting implementation of the protocol
  • Significant pathology of the chest or abdominal wall that would make transthoracic echocardiography impossible (burns, chest trauma, etc.)
  • Children under the age of 18 will not be included in this study

About Intermountain Health Care, Inc.

Intermountain Health Care, Inc. is a leading nonprofit healthcare system based in Salt Lake City, Utah, dedicated to improving community health through innovative clinical practices and rigorous research initiatives. With a commitment to evidence-based care and patient-centered approaches, Intermountain actively sponsors clinical trials that aim to advance medical knowledge and enhance treatment options across various health conditions. The organization leverages its extensive network of hospitals, outpatient facilities, and specialized care services to facilitate high-quality research while prioritizing patient safety and ethical standards. Through collaboration with healthcare professionals and academic institutions, Intermountain Health Care strives to contribute significantly to the advancement of healthcare practices and outcomes.

Locations

Murray, Utah, United States

Patients applied

0 patients applied

Trial Officials

Michael Lanspa, MD

Principal Investigator

Intermountain Health Care, Inc.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials